Skip to main content

Day: September 11, 2025

Capgemini launches its twelfth Employee Share Ownership Plan

Media relations:Victoire GruxTel.: +33 6 04 52 16 55victoire.grux@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Capgemini launches its twelfth Employee Share Ownership Plan Paris, September 11, 2025 – Capgemini announces the launch of its twelfth Employee Share Ownership Plan (ESOP). This new employee share ownership plan is offered to approximately 98% of the employees and is part of the Group’s policy to associate all employees with its development and performance. This ESOP will be implemented through a capital increase reserved for the Capgemini employees for a maximum of 2,700,000 shares (i.e. 1.58% of outstanding shares). As the 2020 ESOP reaches its term at the end of the year, this twelfth plan will help maintain employee shareholding at around 8% of Capgemini SE’s share capital. As...

Continue reading

Treasury Bill Auction Announcement – RIKV 26 0318

Series RIKV 26 0318ISIN IS0000038016Maturity Date 03/18/2026Auction Date 09/15/2025Settlement Date 09/17/2025On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bills in the Series, with the ISIN number and with the Maturity Date according to the table above. Payments for the Treasury bills must be received by the Central Bank before 14:00 on the Settlement Date and the Bills will be delivered in electronic form on the same day. Further reference is made to the General Terms of Icelandic Treasury bills and General Terms of Auction for Treasury bills on the Government Debt Management website. For additional information please contact Oddgeir Gunnarsson, Government Debt Management, at +354 569 9635.

Continue reading

SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025

Press release – No.13 / 2025 SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025 Copenhagen, Denmark, September 11, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that it will host a Capital Markets Day in London on December 11, 2025, featuring presentations from management and external experts in obesity. “Obesity is one of the greatest healthcare challenges of our time, and we are in the very early stages of a rapidly evolving market for weight loss therapies. With a differentiated pipeline targeting obesity and related comorbidities, strong partnerships supporting our leading programs, and a solid financial foundation, we are well positioned to realize our vision...

Continue reading

HII Increases Throughput, Expands Industrial Base through Distributed Shipbuilding

NEWPORT NEWS, Va., Sept. 11, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) is partnering with shipyards and fabricators in multiple states to grow its throughput and meet the increased demand for ships by the U.S. Navy. With its customer’s support, HII is bringing the work to more companies and more jobs in more states, expanding capacity of the U.S. shipbuilding industrial base and improving schedule adherence for all ships built by HII. “HII is all in on our commitment to grow our throughput and turn out more ships at both yards more quickly for the Navy,” HII CEO and President Chris Kastner said. “We’ve already doubled our outsourced hours in 2025 and we are on track to quadruple them in a two year period. Our hiring is up, our attrition is down, and our experience base is growing.” HII’s structural assembly network, consisting of...

Continue reading

InnovAge Named as One of the Nation’s Best Workplaces in Aging Services™ by Fortune® and Great Place to Work®

A Leading Provider of PACE, Ranked in Top Tier of 2025 Best in Aging Services Category DENVER, Sept. 11, 2025 (GLOBE NEWSWIRE) — InnovAge (NASDAQ: INNV), a leading provider of Program of All-Inclusive Care for the Elderly (PACE), has been named to the Fortune Best Workplaces in Aging Services ranking among the top 15 organizations in the aging services category nationwide in 2025. This recognition highlights InnovAge’s commitment to creating a culture where employees feel supported, valued, and inspired to deliver high-quality, compassionate care to older adults. InnovAge employs more than 2,400 team members across multiple states. Because of its dedicated team, through PACE, InnovAge is able to offer participants 24/7 personalized, wraparound medical and social support that is helping thousands of seniors stay in their homes where...

Continue reading

The Court has approved the Restructuring Plan of AUGA group, RAB, and the Ruling on the Plan has entered into force

As announced previously on August 12, 2025, both the shareholders, and on August 18, 2025, the creditors, approved the draft restructuring plan of AUGA group, RAB, legal entity code 126264360 (hereinafter – the Company). Following the voting of the creditors and the shareholders for the Company’s proposed draft restructuring plan, it was submitted to the Vilnius Regional Court, which, by its ruling of September 2, 2025, approved the plan. The ruling on the Company’s restructuring plan entered into legal force on September 11, 2025. This court ruling marks a new stage in the Company’s restructuring process, which will now be implemented starting from the date it enters into force. “The official court approval of the restructuring plan is an important step in our restructuring journey. It allows us to begin real changes aimed at settling...

Continue reading

Fengate expands healthcare infrastructure portfolio with acquisition of 24 U.S. outpatient facilities

MIAMI, Sept. 11, 2025 (GLOBE NEWSWIRE) — Fengate Asset Management (Fengate) is pleased to announce the acquisition of a portfolio of 24 medical outpatient facilities from a top United States (U.S.) healthcare system under a sale-leaseback agreement. The facilities, located across two states, add more than 900,000 square feet of medical space to Fengate’s growing healthcare portfolio. The firm has been investing in social infrastructure since 2006 and manages more than 55 healthcare assets across the U.S. and Canada. “Fengate is proud to partner with one of the largest and strongest not-for-profit health systems in the U.S. on this transaction alongside our partner, MedCraft,” said Mac Bell, Managing Director, Head of Social and Transportation at Fengate. The transaction is the first acquisition by the Fengate-MedCraft joint venture. “We...

Continue reading

SAP Completes Acquisition of SmartRecruiters, Delivering Innovation and AI-Powered Recruiting Differentiation for Global Enterprises

SAN FRANCISCO, Sept. 11, 2025 (GLOBE NEWSWIRE) —  SAP SE (NYSE: SAP) today announced it has completed the acquisition of SmartRecruiters, the Recruiting AI Company. Together, SAP and SmartRecruiters will accelerate innovation in talent acquisition while giving customers confidence, flexibility, scale, and the only platform built to meet the full spectrum of enterprise hiring needs, helping organizations attract, engage, and hire top talent. Innovation at Speed With SAP’s global scale and SmartRecruiters’ category-defining platform, customers can expect faster delivery of AI-powered capabilities, end-to-end orchestrated talent solutions, and user experiences that directly support business outcomes. The combined roadmap will accelerate innovation across candidate engagement, recruiter efficiency, and hiring manager experience. One-of-a-Kind...

Continue reading

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

RA’ANANA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company“), a pioneer in innovative life-support and diagnostic technologies, today announced pivotal results for its HYLA blood sensor, achieving 97.35% accuracy in its latest performance testing phase that will support its upcoming U.S. Food and Drug Administration (“FDA”) submission. These results represent a significant advancement from the initial data obtained in a clinical study, as announced on March 4, 2025. The clinical study from March, conducted at a medical center ranked among the world’s leading hospitals, provided validation for HYLA’s performance, while these latest test results confirm the device’s readiness for the regulatory...

Continue reading

LiveOne (Nasdaq: LVO) Restarted $12 Million Stock Buyback Program

• Repurchased 5M+ shares• $5.9M remaining in program• Senior Management and Directors, led By Robert Ellin, Chairman and CEO, to purchase up to 5M shares LOS ANGELES, Sept. 11, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, today announced an update on its previously authorized $12 million stock repurchase program. “We believe our stock remains significantly undervalued, and this commitment reflects our strong confidence in LiveOne’s growth trajectory and long-term value,” said Robert Ellin, Chairman and CEO of LiveOne. About LiveOneHeadquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO) is an award-winning, creator-first, music, entertainment, and technology platform focused on delivering premium experiences and content worldwide through memberships...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.